chartexchange

NVO
Novo-Nordisk A/S
stockNYSEADR

At CloseOct 30, 2026 4:58:30 PM EDT
39.97USD+2.121%(+0.83)15,277,511
Pre-marketOct 30, 2026 10:29:58 AM EDT
39.74USD+1.533%(+0.60)
Loading…
Loading…
176.30B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$39.14
Beta
0.95
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$41.23
SMA 200
$44.19
Avg. Vol 10D
9.33M
Avg. Vol 30D
13.38M
Avg. Vol 90D
11.98M
Relative Vol
1.14
3.17B
37,436,108
0.2800%
10,000,000
1,902
Nov 4, 2026 (3d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
NVO Profile

Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.

NVO Performance
PeriodPriceDateChangeBeta
1W39.052026-10-23+2.36%-1.278
1M37.402026-10-01+6.87%-0.329
3M47.082026-07-31-15.10%-0.329
6M43.882026-05-01-8.91%-0.133
1Y49.462025-10-31-19.19%0.954
2Y111.952024-10-31-64.30%—
5Y54.722021-11-01-26.95%0.664
NVO Stock Summary

Novo-Nordisk A/S (NYSE:NVO) stock price today is $39.97, and today's volume is 15,277,511. NVO is up 2.121% today. The 30 day average volume is 13.38M. NVO market cap is $176.30B with 4.41B shares outstanding.